Abstract:Objective To explore the effects of dialysate calcium concentrations (DCC)on risks of adverse reactions occurred in maintenance hemodialysis patients during dialysis. Methods The subjects were end-stage renal disease (ESRD)patients in stable condition who were treated with maintenance dialysis in the First Affiliated Hospital,Zhejiang University from June to October 2016. According to the DCC,the patients were randomly divided into 3 groups,the 1.25 mmol/L group,the 1.35 mmol/L group,and the 1.50 mmol/L group;the observation time was 12 weeks. The urea clearance index Kt/V,urea reduction rate (URR),mean arterial pressure before and after dialysis,the serum calcium,serum phosphorus,intact parathyroid hormone (iPTH),and alkaline phosphatase (ALP)levels before and after dialysis,and the incidence of muscle spasm,nausea and vomiting,headache,chest tightness,and arrhythmia in hemodialysis patients in the 3 groups were compared. Results A total of 273 patients entered the study,including 159 males and 114 females with ages from 25 to 83 years and average age of (52 ± 9)years. Each of the 1.25 mmol/L,1.35 mmol/L,and 1. 50 mmol/L groups comprised 91 patients. The differences of baseline data in patients in the 3 groups were not statistically significant (P＞0.05). After 12 weeks of hemodialysis,the differences of Kt/V and URR in patients in the 3 groups were not statistically significant (all P＞0.05);the differences of the mean arterial pressures in patients in the 1.25 and 1.35 mmol/L groups [(102 ± 9)and (103 ±11)mmHg,respectively]were not statistically significant (all P ＞0.0.5);the mean arterial pressure in the patients in the 1.50 mmol/L group was higher than that before hemodialysis [(120 ± 12) mmHg vs.(103 ± 9)mmHg,P＜0.01]and was higher markedly than that in 1.25 and 1.35 mmol/L groups (all P＜0.01);the serum calcium level in patients in the 1.25 mmol/L group was lower than that before hemodialysis [(1.94 ± 0.31)mmol/L vs.(2.24 ± 0.18)mmol/L,P＜0.01];the serum calcium level in the patients in the 1.50 mmol/L group was higher than that before hemodialysis [(2.54 ± 0.18) mmol/L vs.(2.24 ± 0.17)mmol/L,P＜0.01];the iPTH and ALP levels in patients in the 1.25 mmol/L group were higher than those before hemodialysis [(356 ± 68)U vs.(291 ± 49)U,(443 ± 45)U vs. (343 ± 58)U,all P ＜0.01]. During dialysis,the incidence of muscle spasm in patients in the 1.25 mmol/L group was higher than that in the 1.35 mmol/L and 1.50 mmol/L groups [14.28% (13/91)vs. 5.49% (5/91)and 4.39% (4/91),all P ＜0.05];the incidence of headache in patients in the 1.50 mmol/L group was higher than that in the 1.25 mmol/L and 1.35 mmol/L groups [14.28% (13/91)vs. 3.30% (3/91)and 5.49% (5/91),P ＝0.01 and P ＜0.05]. The differences in incidences of chest tightness,arrhythmia,nausea and vomiting were not statistically significant (all P＞0.05). Conclusion The dialysate with calcium concentration of 1.35 mmol/L may reduce the incidence of muscle spasm,does not increase the incidence of hypertension and headache,and effectively reduce the risk of adverse reactions in maintenance hemodialysis patients,while ensuring the adequacy of dialysis.

Effect of Hematocrit on Urea Clearance During Hemodialysis

The Effect of Urea on Hemorheology in Pig

The Influence of Different Blood Purification Methods on Anemia of Uremic Patients

Primary Clinical Experience in High Risk Uremic Patients Converted from Conventional to Short Daily Hemodialysis

The effect of continuous renal replacement therapy in patients with acute kidney injury on the serum levels of urea,creatinine and cystatin C

Parathyroid Hormone Clearance Effect in Uremic Patients by Hemoperfusion with Different Blood Flow Rate

Randomized Controlled Trial of Dialysate Calcium Concentrations on Risks of Adverse Reactions in Hemodialysis Patients During Dialysis

A Comparative Study of the Performance of High-Flux Versus Low-Flux Hemodialysis

Clearance of protein-bound uremic toxins associated with cardiovascular disease in high-flux hemodialysis

The effect of on-line hemodiafiltration on hypertension in patients with end-stage renal disease

Influences of Hemodialysis and Uremia on Serum Levels of Tumor Markers

Effect of Single Hemoperfusion Combined with Hemodialysis on Macromolecular Uremic Toxin

The Cause and Effect Correlation Analysis Between Decreasing Progressively Blood Flows of Access and Kt/V and Urea Reduction Ratio With Clinic Condition of Chronic Maintenance Hemodialysis Patients

Relationship Between Ultrafiltration Rate and Cardiovascular Death in Maintenance Hemodialysis Patients

Effect of Blood and Dialysate Flow Rate on Solute Clearance at Low Dialysate Flow Rate in Daily Hemodialysis

Effects of different reuse methods of hemodialyzer on solute clearance rate in various continuous venovenous hemodiafiltration

Acute Effect of One Session of Hemodiafiltration with Endogenous Reinfusion on Uremic Toxins and Inflammatory Mediators.

The effect of ultrafiltration volume on blood pressure for patients with maintenance hemodialysis

Effects of High Flux Hemodialysis on TLC, Immunoglobulin Level and QOL in TreatmentChronic Renal Failure Uremia

The clinical study on dialysis effect and nutritional status of different dialysis modes

A comparison between residual renal function and peritoneal clearance for Na/H2O and urea removal in peritoneal dialysis patients.